These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19584440)

  • 21. Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: glia dictates resistance versus vulnerability to neurodegeneration.
    Morale MC; Serra PA; L'episcopo F; Tirolo C; Caniglia S; Testa N; Gennuso F; Giaquinta G; Rocchitta G; Desole MS; Miele E; Marchetti B
    Neuroscience; 2006; 138(3):869-78. PubMed ID: 16337092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corticotropin-releasing hormone protects neurons against insults relevant to the pathogenesis of Alzheimer's disease.
    Pedersen WA; McCullers D; Culmsee C; Haughey NJ; Herman JP; Mattson MP
    Neurobiol Dis; 2001 Jun; 8(3):492-503. PubMed ID: 11442356
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides.
    Gallardo G; Schlüter OM; Südhof TC
    Nat Neurosci; 2008 Mar; 11(3):301-8. PubMed ID: 18297066
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modeling Alzheimer's disease in transgenic mice.
    Duff K
    J Fla Med Assoc; 1994 Sep; 81(9):625-8. PubMed ID: 7964589
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Learning and memory in transgenic mice modeling Alzheimer's disease.
    Ashe KH
    Learn Mem; 2001; 8(6):301-8. PubMed ID: 11773429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mitochondrial amyloid-beta levels are associated with the extent of mitochondrial dysfunction in different brain regions and the degree of cognitive impairment in Alzheimer's transgenic mice.
    Dragicevic N; Mamcarz M; Zhu Y; Buzzeo R; Tan J; Arendash GW; Bradshaw PC
    J Alzheimers Dis; 2010; 20 Suppl 2():S535-50. PubMed ID: 20463404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration.
    Saxena S; Caroni P
    Neuron; 2011 Jul; 71(1):35-48. PubMed ID: 21745636
    [TBL] [Abstract][Full Text] [Related]  

  • 29. First signs of glaucoma injury occur in the brain. What has generally been considered an eye disease is actually related to conditions such as Alzheimer's and Parkinson's diseases.
    Duke Med Health News; 2010 May; 16(5):4-5. PubMed ID: 20518132
    [No Abstract]   [Full Text] [Related]  

  • 30. Lessons on Differential Neuronal-Death-Vulnerability from Familial Cases of Parkinson's and Alzheimer's Diseases.
    Franco R; Navarro G; Martínez-Pinilla E
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31277513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Selective vulnerability in neurodegeneration: insights from clinical variants of Alzheimer's disease.
    Mattsson N; Schott JM; Hardy J; Turner MR; Zetterberg H
    J Neurol Neurosurg Psychiatry; 2016 Sep; 87(9):1000-4. PubMed ID: 26746185
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autophagy at synapses in neurodegenerative diseases.
    Lee W; Kim SH
    Arch Pharm Res; 2019 May; 42(5):407-415. PubMed ID: 30937842
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective functional, regional, and neuronal vulnerability in frontotemporal dementia.
    Seeley WW
    Curr Opin Neurol; 2008 Dec; 21(6):701-7. PubMed ID: 18989116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The basis of cellular and regional vulnerability in Alzheimer's disease.
    Mrdjen D; Fox EJ; Bukhari SA; Montine KS; Bendall SC; Montine TJ
    Acta Neuropathol; 2019 Nov; 138(5):729-749. PubMed ID: 31392412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Alzheimer's disease may spread through linked nerve cells. New study counters long-held beliefs that the disease develops in all directions.
    Duke Med Health News; 2012 Jun; 18(6):6. PubMed ID: 22768784
    [No Abstract]   [Full Text] [Related]  

  • 36. Alzheimer's disease, Parkinson's disease, and motoneurone disease: abiotrophic interaction between ageing and environment?
    Calne DB; Eisen A; McGeer E; Spencer P
    Lancet; 1986 Nov; 2(8515):1067-70. PubMed ID: 2877227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Linking selective vulnerability to cell death mechanisms in Parkinson's disease.
    Dickson DW
    Am J Pathol; 2007 Jan; 170(1):16-9. PubMed ID: 17200178
    [No Abstract]   [Full Text] [Related]  

  • 38. Selective neuronal vulnerability in Alzheimer's disease.
    Wang ZT; Zhang C; Wang YJ; Dong Q; Tan L; Yu JT
    Ageing Res Rev; 2020 Sep; 62():101114. PubMed ID: 32569730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cytoskeletal alterations might account for the phylogenetic vulnerability of the human brain to Alzheimer's disease.
    Di Patre PL
    Med Hypotheses; 1991 Feb; 34(2):165-70. PubMed ID: 2041492
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective vulnerability in neurodegenerative diseases.
    Fu H; Hardy J; Duff KE
    Nat Neurosci; 2018 Oct; 21(10):1350-1358. PubMed ID: 30250262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.